26.02.2020 • Topics

Webinar: Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing

© poba/Getty Images
© poba/Getty Images

Life Sciences industry is undergoing a fundamental shift, driven by new technologies, e.g. personalized medicines, digital health, continuous processes, as well as the drive to lower healthcare cost and changes in re-imbursement to a value-based pricing model.

Digitalization is instrumental in facilitating a successful transformation to a flexible, agile and cost-effective pharma manufacturing. Virtual twins can significantly improve the quality and efficiency of projects in engineering and commissioning as well as help improve performance during operations and maintenance.

 

Discover How Virtual Twin Experiences Add Value in Life Sciences Manufacturing
March 26, 2020 | 10.00 a.m. (CET)

           

Join this webinar to:

  • Understand the current industry challenges and the limitations of current approaches
  • Discover how using a virtual twin approach can bring value
  • Learn from practical experiences

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read